Free Trial
NASDAQ:CRMD

CorMedix Q1 2025 Earnings Report

CorMedix logo
$9.65 +0.46 (+5.01%)
Closing price 04:00 PM Eastern
Extended Trading
$9.57 -0.08 (-0.83%)
As of 04:22 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

CorMedix EPS Results

Actual EPS
N/A
Consensus EPS
$0.20
Beat/Miss
N/A
One Year Ago EPS
N/A

CorMedix Revenue Results

Actual Revenue
N/A
Expected Revenue
$38.90 million
Beat/Miss
N/A
YoY Revenue Growth
N/A

CorMedix Announcement Details

Quarter
Q1 2025
Time
Before Market Opens
Conference Call Date
Tuesday, May 6, 2025
Conference Call Time
8:30AM ET

Conference Call Resources

CorMedix Earnings Headlines

Donald Trump is about to free crypto from its chains …
Sure enough, Bitcoin took off on the exact day Juan said it would. It's up more than 40% since the election … surpassing $100,000 on Dec. 8 .… Now Juan believes it could hit $150,000 … or higher in 2025.
CorMedix reports preliminary Q1 revenue $39M, consensus $32.2M.
See More CorMedix Headlines
Get Earnings Announcements in your inbox

Want to stay updated on the latest earnings announcements and upcoming reports for companies like CorMedix? Sign up for Earnings360's daily newsletter to receive timely earnings updates on CorMedix and other key companies, straight to your email.

About CorMedix

CorMedix (NASDAQ:CRMD), a biopharmaceutical company, focuses on developing and commercializing therapeutic products for the prevention and treatment of infectious and inflammatory diseases in the United States. Its lead product candidate is DefenCath, an antimicrobial catheter lock solution to reduce the incidence of catheter-related bloodstream infections in adult patients with kidney failure. The company was formerly known as Picton Holding Company, Inc. and changed its name to CorMedix, Inc. in January 2007. CorMedix Inc. was incorporated in 2006 and is based in Berkeley Heights, New Jersey.

View CorMedix Profile

More Earnings Resources from MarketBeat